Publications by authors named "Robyn Levy"

Claim this Profile
C
Contributions of advanced practice nurses with a DNP degree during palliative and end-of-life care of children with cancer.
Verna L Hendricks-Ferguson, Terrah Foster Akard, Jennifer R Madden, Alberta Peters-Herron, Robyn Levy

J Pediatr Oncol Nurs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
Richard L Wasserman, William Lumry, James Harris, Robyn Levy, Mark Stein

J Clin Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
H Henry Li, Dumitru Moldovan, Jonathan A Bernstein, Avner Reshef, Gregor Porebski, Robyn Levy

J Allergy Clin Immunol Pract· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
Marc A Riedl, Jonathan A Bernstein, Henry Li, Avner Reshef, William Lumry, Robyn Levy

Ann Allergy Asthma Immunol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
Marc A Riedl, Robyn J Levy, Daniel Suez, Richard F Lockey, James W Baker

Ann Allergy Asthma Immunol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
Againdra K Bewtra, Robyn J Levy, Kraig W Jacobson, Richard L Wasserman, Thomas Machnig

Allergy Asthma Proc· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Timothy J Craig, Againdra K Bewtra, David Hurewitz, Robyn Levy, Gerti Janss

Allergy Asthma Proc· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks.
Michael J Prematta, Againdra K Bewtra, Robyn J Levy, Richard L Wasserman, Kraig W Jacobson

Adv Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of peripheral attacks in hereditary angioedema patients.
Andy Kusuma, Anurag Relan, André C Knulst, Dumitru Moldovan, Bruce Zuraw, Robyn J Levy

Am J Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
Marc A Riedl, David S Hurewitz, Robyn Levy, Paula J Busse, David Fitts

Ann Allergy Asthma Immunol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensity.
Jonathan A Bernstein, Bruce Ritchie, Robyn J Levy, Richard L Wasserman, Againdra K Bewtra

Allergy Asthma Proc· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
William R Lumry, H Henry Li, Robyn J Levy, Paul C Potter, Henriette Farkas

Ann Allergy Asthma Immunol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.
Albert L Sheffer, Marilyn Campion, Robyn J Levy, H Henry Li, Patrick T Horn

J Allergy Clin Immunol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
Richard L Wasserman, Robyn J Levy, Againdra K Bewtra, David Hurewitz, Timothy J Craig

Ann Allergy Asthma Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema.
Timothy J Craig, Richard L Wasserman, Robyn J Levy, Againdra K Bewtra, Lynda Schneider

J Clin Immunol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Bruce Zuraw, Marco Cicardi, Robyn J Levy, Jan H Nuijens, Anurag Relan

J Allergy Clin Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.
Jonathan A Bernstein, Bruce Ritchie, Robyn J Levy, Richard L Wasserman, Againdra K Bewtra

Ann Allergy Asthma Immunol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
Bruce L Zuraw, Paula J Busse, Martha White, Joshua Jacobs, William Lumry, Robyn Levy

N Engl J Med· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecallantide for the treatment of acute attacks in hereditary angioedema.
Marco Cicardi, Robyn J Levy, Donald L McNeil, H Henry Li, Albert L Sheffer

N Engl J Med· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
Marco Cicardi, Aleena Banerji, Francisco Bracho, Alejandro Malbrán, Bernd Rosenkranz, Robyn J Levy

N Engl J Med· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema.
Robyn J Levy, William R Lumry, Donald L McNeil, H Henry Li, Marilyn Campion

Ann Allergy Asthma Immunol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
Timothy J Craig, Robyn J Levy, Richard L Wasserman, Againdra K Bewtra, David Hurewitz

J Allergy Clin Immunol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conservative management of GERD: a case study.
Robyn A Levy, Linda Stamm, Sue E Meiner

Medsurg Nurs· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis